Exact Mass: 177.11849940000002
Exact Mass Matches: 177.11849940000002
Found 262 metabolites which its exact mass value is equals to given mass value 177.11849940000002,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Phenmetrazine
Phenmetrazine is only found in individuals that have used or taken this drug. It is a sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to dextroamphetamine. [PubChem]Phenmetrazine is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron leading to an increase in the release of these monoamines into the extraneuronal space. Dopamine integrates incoming sensory stimuli, initiates and controls fine movement (nigro-neostriatal pathway), controls emotional behavior (midbrain mesolimbic-forebrain system) and controls hypothalamic-pituitary endocrine system (tubero-infundibular system). It is this latter effect on the tubero-infundibular systm that seems to lead to reduced food intake. Phenmetrazine also acts as a monoamine oxidase inhibitor. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants
(S)-Valerianine
Alkaloid from roots of Valeriana officinalis (valerian). (S)-Valerianine is found in tea, fats and oils, and herbs and spices. (S)-Valerianine is found in fats and oils. (S)-Valerianine is an alkaloid from roots of Valeriana officinalis (valerian).
Mephedrone
In 2010, unconfirmed reports speculated about the role mephedrone has played in the deaths of several young people in the UK. By July 2010, mephedrone had been alleged to be involved in 52 fatalities in the UK, but detected in only 38 of these cases. Of the nine that coroners had finished investigating, two were caused directly by mephedrone. The first death reported to be caused by mephedrone use was that of 46-year-old, John Sterling Smith, who had underlying health problems and repeatedly injected the drug. A report in Forensic Science International in August 2010 stated mephedrone intoxication has been recorded as the cause of death in two cases in Scotland. Post mortem samples showed the concentration of mephedrone in their blood was 22 mg/l in one case and 3.3 mg/l in the other. The death of a teenager in the UK in November 2009 was widely reported as being caused by mephedrone, but a report by the coroner concluded she had died from natural causes. In March 2010, the deaths of two teenagers in Scunthorpe were widely reported by the media to be caused by mephedrone. Toxicology reports showed the teenagers had not taken any mephedrone and had died as a result of consuming alcohol and the heroin substitute methadone. According to Fiona Measham, a criminologist who is a member of the ACMD, the reporting of the unconfirmed deaths by newspapers followed the usual cycle of exaggeration, distortion, inaccuracy and sensationalism associated with the reporting of recreational drug use. Mephedrone is a white substance. It is sold most commonly as crystals or a powder, but also in the form of capsules or pills. It can have a distinctive odour, reported to range from a synthetic fishy smell to the smell of vanilla and bleach, stale urine, or electric circuit boards. Mephedrone is one of hundreds of designer drugs or legal highs that have been reported in recent years, including artificial chemicals such as synthetic cannabis and semisynthetic substances such as methylhexaneamine. These drugs are primarily developed to avoid being controlled by laws against illegal drugs, thus giving them the label of designer drugs. According to the European Monitoring Centre for Drugs and Drug Addiction, the synthesis of mephedrone was first reported in 1929 by Saem de Burnaga Sanchez in the Bulletin de la Societe Chimique de France, under the name toluyl-alpha-monomethylaminoethylcetone,:17 but the compound remained an obscure product of academia until 2003, when it was re-discovered and publicised by an underground chemist on The Hive website, working under the pseudonym Kinetic. Mephedrone, also known as 4-methylmethcathinone (4-MMC), or 4-methylephedrone, is a synthetic stimulant drug of the amphetamine and cathinone classes. Slang names include meph, drone, MCAT, meow meow, and bubble. It is reportedly manufactured in China and is chemically similar to the cathinone compounds found in the khat plant of eastern Africa. It comes in the form of tablets or a powder, which users can swallow, snort or inject, producing similar effects to MDMA, amphetamines, and cocaine.
Bethanidine
Bethanidine is only found in individuals that have used or taken this drug. It is a guanidinium antihypertensive agent that acts by blocking adrenergic transmission.Bethanidine, a guanidine derivative, is a peripherally acting antiadrenergic agent which primarily acts as an alpha2a adrenergic agonist. Bethanidine effectively decreases blood pressure by suppressing renin secretion or interfering with function of the sympathetic nervous system. C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CC - Guanidine derivatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
7-Ethyl-2,3,6,7-tetrahydrocyclopent[b]azepin-8(1H)-one
Proline-derived Maillard product. Proline-derived Maillard product
2,3,6,7-Tetrahydro-6,7-dimethylcyclopent[b]azepin-8(1H)-one
Proline-specific Maillard product. Proline-specific Maillard product
1-(2,3-Dihydro-1H-pyrrolizin-5-yl)-1-butanone
Proline-derived Maillard product. Proline-derived Maillard product
2,3-Dihydro-7-methyl-5-propanoyl-1H-pyrrolizine
Proline- or lysine-derived Maillard product. Proline- or lysine-derived Maillard product
2,3-Dihydro-6-methyl-5-propanoyl-1H-pyrrolizine
Proline-derived Maillard product. Proline-derived Maillard product
1-(2,3-Dihydro-5-ethyl-1H-pyrrolizin-7-yl)ethanone
Proline-derived Maillard product. Proline-derived Maillard product
5-Acetyl-2,3-dihydro-6,7-dimethyl-1H-pyrrolizine
Proline-derived Maillard product. Proline-derived Maillard product
1-(2,3-Dihydro-5,6-dimethyl-1H-pyrrolizin-7-yl)ethanone
Proline- or lysine-derived Maillard product. Proline- or lysine-derived Maillard product
2-Propanamine, 2-methyl-N-(phenylmethylene)-, N-oxide
4-(Diethylamino)benzaldehyde
4-Diethylaminobenzaldehyde is a reversible aldehyde dehydrogenases (ALDHs) inhibitor, with a Ki of 4 nM for ALDH1. 4-Diethylaminobenzaldehyde displays potent anti-androgenic effect (IC50= 1.71μM)[1][2].
N-(3-(Aminomethyl)benzyl)acetamidine
D004791 - Enzyme Inhibitors
Metamfepramone
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
N-Formylmethamphetamine
CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 508
7-(methylsulfinyl)heptylamine
A primary amino compound that is heptylamine in which one of the methyl hydrogens at position 7 has been replaced by a methylsulfinyl group.
4-Diethylaminobenzaldehyde
4-Diethylaminobenzaldehyde is a reversible aldehyde dehydrogenases (ALDHs) inhibitor, with a Ki of 4 nM for ALDH1. 4-Diethylaminobenzaldehyde displays potent anti-androgenic effect (IC50= 1.71μM)[1][2].
4-MMC
CONFIDENCE standard compound; EAWAG_UCHEM_ID 2827 CONFIDENCE standard compound; INTERNAL_ID 1696
Rebemide
[Raw Data] CB170_Rebemide_pos_50eV_CB000064.txt [Raw Data] CB170_Rebemide_pos_40eV_CB000064.txt [Raw Data] CB170_Rebemide_pos_30eV_CB000064.txt [Raw Data] CB170_Rebemide_pos_20eV_CB000064.txt [Raw Data] CB170_Rebemide_pos_10eV_CB000064.txt
phenmetrazine
A member of the class of morpholines that is morpholine substituted with a phenyl group at position 2 and a methyl group at position 3. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants
Betanidine
C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CC - Guanidine derivatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
7-ethyl-1H,2H,3H,6H,7H,8H-cyclopenta[b]azepin-8-one
6,7-dimethyl-1H,2H,3H,6H,7H,8H-cyclopenta[b]azepin-8-one
2,3-Dihydro-7-methyl-5-propanoyl-1H-pyrrolizine
2,3-Dihydro-6-methyl-5-propanoyl-1H-pyrrolizine
1-(2,3-Dihydro-5-ethyl-1H-pyrrolizin-7-yl)ethanone
5-Acetyl-2,3-dihydro-6,7-dimethyl-1H-pyrrolizine
1-(2,3-Dihydro-5,6-dimethyl-1H-pyrrolizin-7-yl)ethanone
5-Hepten-2-amine,N,6-dimethyl-, hydrochloride (1:1)
5-amino-6,7,8,9-tetrahydro-5h-benzo[7]annulen-6-ol
(R)-5-METHOXY-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE
(2,2-DIMETHYL-2,3-DIHYDRO-1-BENZOFURAN-7-YL)METHYLAMINE
[1-(1(R)-ALPHA-METHYLBENZYL)-AZIRIDIN-2(R)-YL]-METHANOL
(S)-2-Amino-1,2,3,4-tetrahydro-7-methoxynaphthalene
(S)-2-Amino-1,2,3,4-tetrahydro-6-methoxy-naphthalene
[1-(1(R)-ALPHA-METHYLBENZYL)-AZIRIDINE-2(S)-YL]-METHANOL
(5-amino-5,6,7,8-tetrahydronaphthalen-2-yl)methanol
2-Amino-5-butyl-4-methyl-1H-pyrrole-3-carbonitrile
(S)-(-)-5,5-DIPHENYL-4-(TERT-BUTYL)-2-OXAZOLIDINONE
(1R)-7-methoxy-1,2,3,4-tetrahydronaphthalen-1-amine
(1S)-7-methoxy-1,2,3,4-tetrahydronaphthalen-1-amine
cyclopropylmethyl-(4-methoxy-phenyl)-amine hydrochloride
(4-methyl-5,6,7,8-tetrahydroquinazolin-2-yl)methanamine
(1S)-5-methoxy-1,2,3,4-tetrahydronaphthalen-1-amine
(1R)-5-methoxy-1,2,3,4-tetrahydronaphthalen-1-amine
(2,2-diMethyl-2,3-dihydrobenzofuran-5-yl)MethanaMine
3-[Dimethoxy(methyl)silyl]-N-methyl-1-propanamine
C7H19NO2Si (177.11849940000002)
1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-BORONICACID,PINACOLESTER
ethyl (2S)-2-amino-4-fluoro-4-methylpentanoate,hydrochloride
N-Tert-butyl-alpha-phenylnitrone
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents
Bethanid
C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CC - Guanidine derivatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents